0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Veterinary Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-31X6782
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Veterinary Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31X6782
Report
September 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Drugs - Market Size

The global market for Veterinary Drugs was estimated to be worth US$ 23720 million in 2023 and is forecast to a readjusted size of US$ 34770 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

Veterinary Drugs - Market

Veterinary Drugs - Market

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 23%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Veterinary Drugs by region & country, by Type, and by Application.
The Veterinary Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drugs.
Market Segmentation

Scope of Veterinary Drugs - Market Report

Report Metric Details
Report Name Veterinary Drugs - Market
Forecasted market size in 2030 US$ 34770 million
CAGR 5.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Treatment Drugs
  • Vaccines
  • Others
Segment by Application
  • Chickens
  • Swine
  • Cattle
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco, Bayer AG, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Covetrus, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Veterinary Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Veterinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Veterinary Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Veterinary Drugs - Market size in 2030?

Ans: The Veterinary Drugs - Market size in 2030 will be US$ 34770 million.

What is the Veterinary Drugs - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Veterinary Drugs - Market report?

Ans: The main players in the Veterinary Drugs - Market are Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco, Bayer AG, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Covetrus, Inc.

What are the Application segmentation covered in the Veterinary Drugs - Market report?

Ans: The Applications covered in the Veterinary Drugs - Market report are Chickens, Swine, Cattle, Others

What are the Type segmentation covered in the Veterinary Drugs - Market report?

Ans: The Types covered in the Veterinary Drugs - Market report are Treatment Drugs, Vaccines, Others

1 Market Overview
1.1 Veterinary Drugs Product Introduction
1.2 Global Veterinary Drugs Market Size Forecast
1.3 Veterinary Drugs Market Trends & Drivers
1.3.1 Veterinary Drugs Industry Trends
1.3.2 Veterinary Drugs Market Drivers & Opportunity
1.3.3 Veterinary Drugs Market Challenges
1.3.4 Veterinary Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Drugs Players Revenue Ranking (2023)
2.2 Global Veterinary Drugs Revenue by Company (2019-2024)
2.3 Key Companies Veterinary Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Veterinary Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Veterinary Drugs
2.6 Veterinary Drugs Market Competitive Analysis
2.6.1 Veterinary Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Veterinary Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Treatment Drugs
3.1.2 Vaccines
3.1.3 Others
3.2 Global Veterinary Drugs Sales Value by Type
3.2.1 Global Veterinary Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chickens
4.1.2 Swine
4.1.3 Cattle
4.1.4 Others
4.2 Global Veterinary Drugs Sales Value by Application
4.2.1 Global Veterinary Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Drugs Sales Value by Region
5.1.1 Global Veterinary Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Drugs Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Drugs Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Veterinary Drugs Sales Value, 2019-2030
5.2.2 North America Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Veterinary Drugs Sales Value, 2019-2030
5.3.2 Europe Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Veterinary Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Veterinary Drugs Sales Value, 2019-2030
5.5.2 South America Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Veterinary Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Drugs Sales Value
6.3 United States
6.3.1 United States Veterinary Drugs Sales Value, 2019-2030
6.3.2 United States Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Drugs Sales Value, 2019-2030
6.4.2 Europe Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Drugs Sales Value, 2019-2030
6.5.2 China Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Drugs Sales Value, 2019-2030
6.6.2 Japan Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Drugs Sales Value, 2019-2030
6.7.2 South Korea Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Drugs Sales Value, 2019-2030
6.9.2 India Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis Inc.
7.1.1 Zoetis Inc. Profile
7.1.2 Zoetis Inc. Main Business
7.1.3 Zoetis Inc. Veterinary Drugs Products, Services and Solutions
7.1.4 Zoetis Inc. Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Inc. Recent Developments
7.2 Boehringer Ingelheim Animal Health
7.2.1 Boehringer Ingelheim Animal Health Profile
7.2.2 Boehringer Ingelheim Animal Health Main Business
7.2.3 Boehringer Ingelheim Animal Health Veterinary Drugs Products, Services and Solutions
7.2.4 Boehringer Ingelheim Animal Health Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Ingelheim Animal Health Recent Developments
7.3 Merck Animal Health
7.3.1 Merck Animal Health Profile
7.3.2 Merck Animal Health Main Business
7.3.3 Merck Animal Health Veterinary Drugs Products, Services and Solutions
7.3.4 Merck Animal Health Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Elanco Recent Developments
7.4 Elanco
7.4.1 Elanco Profile
7.4.2 Elanco Main Business
7.4.3 Elanco Veterinary Drugs Products, Services and Solutions
7.4.4 Elanco Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Elanco Recent Developments
7.5 Bayer AG
7.5.1 Bayer AG Profile
7.5.2 Bayer AG Main Business
7.5.3 Bayer AG Veterinary Drugs Products, Services and Solutions
7.5.4 Bayer AG Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Bayer AG Recent Developments
7.6 Ceva Sante Animale S.A.
7.6.1 Ceva Sante Animale S.A. Profile
7.6.2 Ceva Sante Animale S.A. Main Business
7.6.3 Ceva Sante Animale S.A. Veterinary Drugs Products, Services and Solutions
7.6.4 Ceva Sante Animale S.A. Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Ceva Sante Animale S.A. Recent Developments
7.7 Virbac SA
7.7.1 Virbac SA Profile
7.7.2 Virbac SA Main Business
7.7.3 Virbac SA Veterinary Drugs Products, Services and Solutions
7.7.4 Virbac SA Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 Virbac SA Recent Developments
7.8 Vetoquinol SA
7.8.1 Vetoquinol SA Profile
7.8.2 Vetoquinol SA Main Business
7.8.3 Vetoquinol SA Veterinary Drugs Products, Services and Solutions
7.8.4 Vetoquinol SA Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 Vetoquinol SA Recent Developments
7.9 IDEXX Laboratories, Inc.
7.9.1 IDEXX Laboratories, Inc. Profile
7.9.2 IDEXX Laboratories, Inc. Main Business
7.9.3 IDEXX Laboratories, Inc. Veterinary Drugs Products, Services and Solutions
7.9.4 IDEXX Laboratories, Inc. Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 IDEXX Laboratories, Inc. Recent Developments
7.10 Covetrus, Inc.
7.10.1 Covetrus, Inc. Profile
7.10.2 Covetrus, Inc. Main Business
7.10.3 Covetrus, Inc. Veterinary Drugs Products, Services and Solutions
7.10.4 Covetrus, Inc. Veterinary Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 Covetrus, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Veterinary Drugs Industrial Chain
8.2 Veterinary Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Veterinary Drugs Market Trends
    Table 2. Veterinary Drugs Market Drivers & Opportunity
    Table 3. Veterinary Drugs Market Challenges
    Table 4. Veterinary Drugs Market Restraints
    Table 5. Global Veterinary Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Veterinary Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Veterinary Drugs Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Veterinary Drugs Product Type
    Table 9. Key Companies Time to Begin Mass Production of Veterinary Drugs
    Table 10. Global Veterinary Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drugs as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Veterinary Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Veterinary Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Veterinary Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Veterinary Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Veterinary Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Veterinary Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Veterinary Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Veterinary Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Veterinary Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Veterinary Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Veterinary Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Veterinary Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Veterinary Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Veterinary Drugs Sales Value by Region (2019-2024) & (%)
    Table 27. Global Veterinary Drugs Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Veterinary Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Veterinary Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Veterinary Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 31. Zoetis Inc. Basic Information List
    Table 32. Zoetis Inc. Description and Business Overview
    Table 33. Zoetis Inc. Veterinary Drugs Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Veterinary Drugs Business of Zoetis Inc. (2019-2024)
    Table 35. Zoetis Inc. Recent Developments
    Table 36. Boehringer Ingelheim Animal Health Basic Information List
    Table 37. Boehringer Ingelheim Animal Health Description and Business Overview
    Table 38. Boehringer Ingelheim Animal Health Veterinary Drugs Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Veterinary Drugs Business of Boehringer Ingelheim Animal Health (2019-2024)
    Table 40. Boehringer Ingelheim Animal Health Recent Developments
    Table 41. Merck Animal Health Basic Information List
    Table 42. Merck Animal Health Description and Business Overview
    Table 43. Merck Animal Health Veterinary Drugs Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Veterinary Drugs Business of Merck Animal Health (2019-2024)
    Table 45. Merck Animal Health Recent Developments
    Table 46. Elanco Basic Information List
    Table 47. Elanco Description and Business Overview
    Table 48. Elanco Veterinary Drugs Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Veterinary Drugs Business of Elanco (2019-2024)
    Table 50. Elanco Recent Developments
    Table 51. Bayer AG Basic Information List
    Table 52. Bayer AG Description and Business Overview
    Table 53. Bayer AG Veterinary Drugs Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Veterinary Drugs Business of Bayer AG (2019-2024)
    Table 55. Bayer AG Recent Developments
    Table 56. Ceva Sante Animale S.A. Basic Information List
    Table 57. Ceva Sante Animale S.A. Description and Business Overview
    Table 58. Ceva Sante Animale S.A. Veterinary Drugs Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Veterinary Drugs Business of Ceva Sante Animale S.A. (2019-2024)
    Table 60. Ceva Sante Animale S.A. Recent Developments
    Table 61. Virbac SA Basic Information List
    Table 62. Virbac SA Description and Business Overview
    Table 63. Virbac SA Veterinary Drugs Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Veterinary Drugs Business of Virbac SA (2019-2024)
    Table 65. Virbac SA Recent Developments
    Table 66. Vetoquinol SA Basic Information List
    Table 67. Vetoquinol SA Description and Business Overview
    Table 68. Vetoquinol SA Veterinary Drugs Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Veterinary Drugs Business of Vetoquinol SA (2019-2024)
    Table 70. Vetoquinol SA Recent Developments
    Table 71. IDEXX Laboratories, Inc. Basic Information List
    Table 72. IDEXX Laboratories, Inc. Description and Business Overview
    Table 73. IDEXX Laboratories, Inc. Veterinary Drugs Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Veterinary Drugs Business of IDEXX Laboratories, Inc. (2019-2024)
    Table 75. IDEXX Laboratories, Inc. Recent Developments
    Table 76. Covetrus, Inc. Basic Information List
    Table 77. Covetrus, Inc. Description and Business Overview
    Table 78. Covetrus, Inc. Veterinary Drugs Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Veterinary Drugs Business of Covetrus, Inc. (2019-2024)
    Table 80. Covetrus, Inc. Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Veterinary Drugs Downstream Customers
    Table 84. Veterinary Drugs Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Veterinary Drugs Product Picture
    Figure 2. Global Veterinary Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Veterinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Veterinary Drugs Report Years Considered
    Figure 5. Global Veterinary Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Drugs Revenue in 2023
    Figure 7. Veterinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Treatment Drugs Picture
    Figure 9. Vaccines Picture
    Figure 10. Others Picture
    Figure 11. Global Veterinary Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Veterinary Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Chickens
    Figure 14. Product Picture of Swine
    Figure 15. Product Picture of Cattle
    Figure 16. Product Picture of Others
    Figure 17. Global Veterinary Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Veterinary Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Veterinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Veterinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Veterinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Veterinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Veterinary Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Veterinary Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Veterinary Drugs Sales Value (%), (2019-2030)
    Figure 30. United States Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Veterinary Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Veterinary Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Veterinary Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. Veterinary Drugs Industrial Chain
    Figure 52. Veterinary Drugs Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS